Abstract
Using a cell model system established by ectopic expression of a soluble TGFβ type III receptor (sRIII) containing the whole extracellular domain of the type III receptor in human breast cancer MDA-MB-231 cells, we observed that the expression of sRIII antagonized TGFβ activity and inhibited both anchorage-dependent and anchorage-independent cell growth. Further studies revealed that sRIII expression induced apoptosis both in vitro and in vivo. Treatment with TGFβ neutralizing antibodies or a recombinant human sRIII also induced apoptosis in the MDA-MB-231 parental cells, suggesting that the increased apoptosis after sRIII expression was specifically due to antagonization of autocrine TGFβ signaling. Western blotting showed that sRIII clones had a higher PTEN expression level than the control cells did. Treatment with TGFβ1 decreased PTEN and inhibited apoptosis in sRIII cells to a level similar to that in the control cells. sRIII clones also showed a lower level of phosphorylated-Akt than the control cells, consistent with the inhibitory activity of PTEN on Akt activation. Treatment with LY294002, a specific inhibitor of Akt activator, phosphatidylinositol 3-kinase, also induced apoptosis in a dose dependent manner in the control cells. Our results suggest that autocrine TGFβ signaling is necessary for the growth and survival of MDA-MB-231 cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abe T, Ouyang H, Migita T, Kato Y, Kimura M, Shiiba K, Sunamura M, Matsuno S, Horii A . 1996 Eur. J. Surg. Oncol. 22: 474–477
Arteaga CL, Coffey Jr RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM . 1990 Cell Growth Differ. 1: 367–374
Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL . 2000 J. Biol. Chem. 275: 36803–36810
Bandyopadhyay A, Zhu Y, Cibull ML, Bao LW, Chen CG, Sun LZ . 1999 Cancer Res. 59: 5041–5046
Barrett-Lee P, Travers M, Luqmani Y, Coombes RC . 1990 Br. J. Cancer 61: 612–617
Bassing CH, Howe DJ, Segarini PR, Donahoe PK, Wang XF . 1994b J. Biol. Chem. 269: 14861–14864
Bassing CH, Yingling JM, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahoe PK, Wang XF . 1994a Science 263: 87–89
Chen C, Wang XF, Sun LZ . 1997 J. Biol. Chem. 272: 12862–12867
Chen CR, Kang YB, Massague J . 2001 Proc. Natl. Acad. Sci. USA 98: 992–999
Chipuk JE, Bhat M, Hsing AY, Ma JJ, Danielpour D . 2001 J. Biol. Chem. 276: 26614–26621
Coombes RC, Barrett-Lee P, Luqmani Y . 1990 J. Steroid Biochem. Mol. Biol. 37: 833–836
Daly RJ, King RJ, Darbre PD . 1990 J. Cell Biochem. 43: 199–211
Derynck R, Zhang Y, Feng XH . 1998 Cell 95: 737–740
Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L . 1996 Cell 86: 543–552
Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K . 1993 Cell 75: 681–692
Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA . 1992 Cancer Res. 52: 6949–6952
Grady WM, Rajput A, Myeroff L, Liu DF, Kwon KH, Willis J, Markowitz S . 1998 Cancer Res. 58: 3101–3104
Hafez MM, Infante D, Winawer S, Friedman E . 1990 Cell Growth Differ. 1: 617–626
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE . 1996 Science 271: 350–353
Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, Stone EM, Aaltonen LA . 1998 Science 280: 1086–1088
Hsu S, Huang F, Hafez M, Winawer S, Friedman E . 1994 Cell Growth Differ. 5: 267–275
Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, Dijke P, Heldin CH . 2000 Curr. Biol. 10: 535–538
Li DM, Sun H . 1997 Cancer Res. 57: 2124–2129
Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R . 1998 Cancer Res. 58: 5667–5672
Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF . 1992 Cell 68: 775–785
Lopez-Casillas F, Payne HM, Andres JL, Massague J . 1994 J. Cell Biol. 124: 557–568
Lopez-Casillas F, Wrana JL, Massague J . 1993 Cell 73: 1435–1444
Lyons RM, Moses HL . 1990 Eur. J. Biochem. 187: 467–473
Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL . 1996 Cell 87: 1215–1224
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain MG, Willson JKV . 1995 Science 268: 1336–1338
Massague J . 2000 Nat. Rev. Mol. Cell. Biol. 1: 169–178
Massague J, Blain SW, Lo RS . 2000 Cell 103: 295–309
Massague J, Chen YG . 2000 Genes Dev. 14: 627–644
Massagué J . 1998 Annu. Rev. Biochem. 67: 753–791
Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sakitani K, Yamashiki N, Seki T, Saito H, Nishizawa M, Fujisawa J, Inoue K . 2000 Cancer Res. 60: 1394–1402
Miettinen PJ, Ebner R, Lopez AR, Derynck R . 1994 J. Cell Biol. 127: 2021–2036
Mulder KM, Brattain MG . 1989 Mol. Endocrinol. 3: 1215–1222
Murphy CS, Pietenpol JA, Munger K, Howley PM, Moses HL . 1991 Cold Spring Harb. Symp. Quant. Biol. 56: 129–135
Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang YJ, Lee HY, Park JG, Lynch HT, Roberts AB, Vogelstein B, Markowitz SD . 1995 Cancer Res. 55: 5545–5547
Oft M, Heider KH, Beug H . 1998 Curr. Biol. 8: 1243–1252
Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA . 2001 Nat. Cell. Biol. 3: 708–714
Piek E, Heldin CH, ten Dijke P . 1999 FASEB J. 13: 2105–2124
Reiss M . 1999 Microbes and Infection 1: 1327–1347
Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S . 1997 Cancer Res. 57: 2578–2580
Roberts AB, Sporn MB (ed) . 1991 The transforming growth factor-betas: Peptide growth factors and their receptors Sporn MB and Roberts AB (eds) Heidelberg: Springer-Verlag pp. 419–472
Sanchez A, Alvarez AM, Benito M, Fabregat I . 1996 J. Biol. Chem. 271: 7416–7422
Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA, Kern SE . 1996 Cancer Res. 56: 2527–2530
Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL . 2001 Mol. Biol. Cell 12: 3328–3339
Simpson L, Parsons R . 2001 Exp. Cell Res. 264: 29–41
Sun L, Chen C . 1997 J. Biol. Chem. 272: 25367–25372
Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG . 1994 J. Biol. Chem. 269: 26449–26455
Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ, Wakefield LM . 1998 Nat. Med. 4: 802–807
Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, Toda T . 1999 Breast Cancer Res. Treat. 53: 33–39
Vilchis-Landeros MM, Montiel L, Mendoza V, Mendoza-Hernandez G, Lopez-Casillas F . 2001 Biochem. J. 355: 215–222
Walker RA, Gallacher B . 1995 J. Pathol. 177: 123–127
Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S . 2000 Cancer Res. 60: 4507–4512
Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HJ, Weinberg RA . 1991 Cell 67: 797–805
Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH . 2000 Cancer Res. 60: 2002–2006
Wrana JL, Attisano L, Wieser R, Ventura F, Massague J . 1994 Nature 370: 341–347
Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG . 1992 J. Cell Biol. 116: 187–196
Yamamura Y, Hua XX, Bergelson S, Lodish SF . 2000 J. Biol. Chem. 275: 36295–36302
Yan Z, Deng X, Friedman E . 2001 J. Biol. Chem. 276: 1555–1563
Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massague J, Mundy GR, Guise TA . 1999 J. Clin. Invest. 103: 197–206
Zar JH . 1984 Biostatistical Analysis Zar JH (ed) Englewood Cliffs, N.J.: Prentice-Hall, Inc pp. 122–149
Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE . 1998 Mol. Cell 1: 611–617
Zentella A, Weis FM, Ralph DA, Laiho M, Massague J . 1991 Mol. Cell. Biol. 11: 4952–4958
Acknowledgements
This work was supported by National Institutes of Health Grants CA75253 and CA79683 to L-Z Sun. The pSBE4-Luc plasmid was a kind gift from Dr Bert Vogelstein.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lei, X., Bandyopadhyay, A., Le, T. et al. Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells. Oncogene 21, 7514–7523 (2002). https://doi.org/10.1038/sj.onc.1205966
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205966
Keywords
This article is cited by
-
Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
Nature Communications (2016)
-
Stiffened Extracellular Matrix and Signaling from Stromal Fibroblasts via Osteoprotegerin Regulate Tumor Cell Invasion in a 3-D Tumor in Situ Model
Cancer Microenvironment (2016)
-
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
Journal of Biomedical Science (2013)
-
Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression
Clinical & Experimental Metastasis (2011)